AU2014248742B2 - Processes for the preparation of an apoptosis-inducing agent - Google Patents
Processes for the preparation of an apoptosis-inducing agent Download PDFInfo
- Publication number
- AU2014248742B2 AU2014248742B2 AU2014248742A AU2014248742A AU2014248742B2 AU 2014248742 B2 AU2014248742 B2 AU 2014248742B2 AU 2014248742 A AU2014248742 A AU 2014248742A AU 2014248742 A AU2014248742 A AU 2014248742A AU 2014248742 B2 AU2014248742 B2 AU 2014248742B2
- Authority
- AU
- Australia
- Prior art keywords
- compound
- formula
- tert
- combining
- organic solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- LQBVNQSMGBZMKD-UHFFFAOYSA-N CC1(C)CC(c(cc2)ccc2Cl)=C(CN(CC2)CCN2c(cc2)cc(Oc3cnc4[nH]ccc4c3)c2C(NS(c(cc2[N+]([O-])=O)ccc2NCC2CCOCC2)(=O)=O)=O)CC1 Chemical compound CC1(C)CC(c(cc2)ccc2Cl)=C(CN(CC2)CCN2c(cc2)cc(Oc3cnc4[nH]ccc4c3)c2C(NS(c(cc2[N+]([O-])=O)ccc2NCC2CCOCC2)(=O)=O)=O)CC1 LQBVNQSMGBZMKD-UHFFFAOYSA-N 0.000 description 1
- DMRMYQUGHOAQFW-UHFFFAOYSA-N CC1(C)CC(c(cc2)ccc2Cl)=C(CN(CC2)CCN2c2ccc(C(O)=O)c(Oc3cnc4[nH]ccc4c3)c2)CC1 Chemical compound CC1(C)CC(c(cc2)ccc2Cl)=C(CN(CC2)CCN2c2ccc(C(O)=O)c(Oc3cnc4[nH]ccc4c3)c2)CC1 DMRMYQUGHOAQFW-UHFFFAOYSA-N 0.000 description 1
- YCNNHDUZLQPKJY-UHFFFAOYSA-N CC1(C)CC(c(cc2)ccc2Cl)=C(CN2CCNCC2)CC1 Chemical compound CC1(C)CC(c(cc2)ccc2Cl)=C(CN2CCNCC2)CC1 YCNNHDUZLQPKJY-UHFFFAOYSA-N 0.000 description 1
- YYXWUBVCFVWUTQ-UHFFFAOYSA-N CC1(CCC(CNc(cc2)c(C)cc2[S](=O)=O)CC1)O Chemical compound CC1(CCC(CNc(cc2)c(C)cc2[S](=O)=O)CC1)O YYXWUBVCFVWUTQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/455—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation with carboxylic acids or their derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/38—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings
- C07C47/457—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Health & Medical Sciences (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Compounds Of Unknown Constitution (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2018203977A AU2018203977B2 (en) | 2013-03-13 | 2018-06-05 | Processes for the preparation of an apoptosis-inducing agent |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361780621P | 2013-03-13 | 2013-03-13 | |
| US61/780,621 | 2013-03-13 | ||
| US201461947850P | 2014-03-04 | 2014-03-04 | |
| US61/947,850 | 2014-03-04 | ||
| PCT/US2014/024224 WO2014165044A1 (en) | 2013-03-13 | 2014-03-12 | Processes for the preparation of an apoptosis-inducing agent |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2018203977A Division AU2018203977B2 (en) | 2013-03-13 | 2018-06-05 | Processes for the preparation of an apoptosis-inducing agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2014248742A1 AU2014248742A1 (en) | 2015-09-10 |
| AU2014248742B2 true AU2014248742B2 (en) | 2018-04-05 |
Family
ID=50439506
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2014248742A Active AU2014248742B2 (en) | 2013-03-13 | 2014-03-12 | Processes for the preparation of an apoptosis-inducing agent |
| AU2018203977A Active AU2018203977B2 (en) | 2013-03-13 | 2018-06-05 | Processes for the preparation of an apoptosis-inducing agent |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2018203977A Active AU2018203977B2 (en) | 2013-03-13 | 2018-06-05 | Processes for the preparation of an apoptosis-inducing agent |
Country Status (31)
| Country | Link |
|---|---|
| EP (5) | EP3293185A1 (ja) |
| JP (2) | JP6357220B2 (ja) |
| KR (1) | KR102230339B1 (ja) |
| CN (3) | CN105164128B (ja) |
| AU (2) | AU2014248742B2 (ja) |
| BR (3) | BR112015021540B1 (ja) |
| CA (3) | CA3090936C (ja) |
| CL (1) | CL2015002548A1 (ja) |
| CR (1) | CR20150495A (ja) |
| CY (1) | CY1120576T1 (ja) |
| DK (1) | DK2970263T3 (ja) |
| ES (1) | ES2683378T3 (ja) |
| HK (2) | HK1216644A1 (ja) |
| HR (1) | HRP20181273T1 (ja) |
| HU (1) | HUE039046T2 (ja) |
| IL (2) | IL240779B (ja) |
| LT (1) | LT2970263T (ja) |
| MX (1) | MX365343B (ja) |
| MY (1) | MY192466A (ja) |
| PE (2) | PE20191685A1 (ja) |
| PH (2) | PH12015501960A1 (ja) |
| PL (1) | PL2970263T3 (ja) |
| PT (1) | PT2970263T (ja) |
| RS (1) | RS57569B1 (ja) |
| RU (1) | RU2660424C2 (ja) |
| SG (2) | SG10201701680YA (ja) |
| SI (1) | SI2970263T1 (ja) |
| TW (2) | TWI631121B (ja) |
| UA (1) | UA118667C2 (ja) |
| UY (3) | UY39848A (ja) |
| WO (1) | WO2014165044A1 (ja) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104370905B (zh) * | 2014-10-22 | 2016-06-01 | 南京友杰医药科技有限公司 | Bcl-2抑制剂ABT-199的合成 |
| US11001582B2 (en) | 2016-03-10 | 2021-05-11 | Assia Chemical Industries Ltd. | Solid state forms of Venetoclax and processes for preparation of Venetoclax |
| CN107089981A (zh) * | 2017-04-24 | 2017-08-25 | 杭州科耀医药科技有限公司 | 一种BCL‑2抑制剂Venetoclax的合成方法 |
| CN111448198B (zh) | 2017-08-23 | 2023-02-03 | 广州麓鹏制药有限公司 | 作为治疗新生性疾病的Bcl-2抑制剂的缩合杂环衍生物 |
| CN108037196B (zh) * | 2017-11-23 | 2020-06-23 | 中山奕安泰医药科技有限公司 | 一种3-硝基-4-[[(四氢-2h-吡喃-4-基)甲基]氨基]苯磺酰胺的检测方法 |
| JP2021510165A (ja) | 2018-01-10 | 2021-04-15 | リキュリウム アイピー ホールディングス リミテッド ライアビリティー カンパニー | ベンズアミド化合物 |
| WO2020003272A1 (en) | 2018-06-29 | 2020-01-02 | Fresenius Kabi Oncology Ltd. | An improved process for the preparation of venetoclax |
| CN108997333A (zh) * | 2018-07-04 | 2018-12-14 | 江苏中邦制药有限公司 | 一种b细胞淋巴瘤因子-2抑制剂abt-199的制备方法 |
| WO2020023435A1 (en) | 2018-07-24 | 2020-01-30 | Albany Molecular Research, Inc. | Venetoclax basic salts and processes for the purification of venetoclax |
| US11903950B2 (en) | 2018-08-22 | 2024-02-20 | Newave Pharmaceutical Inc. | BCL-2 inhibitors |
| WO2020049599A1 (en) * | 2018-09-07 | 2020-03-12 | Msn Laboratories Private Limited, R&D Center | Process for the preparation of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1- yl]methyl}piperazin-1-yl)-n-({3-nitro-4-[(tetrahydro-2h-pyran-4-ylmethyl)amino] phenyl}sulfonyl)-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide) |
| CN112079795B (zh) * | 2020-09-16 | 2022-12-09 | 广东莱佛士制药技术有限公司 | 一种维奈托克中间体及其类似物的合成方法 |
| IT202100025976A1 (it) | 2021-10-06 | 2023-04-06 | Univ Degli Studi Di Perugia | Combinazione di principi attivi per il trattamento della leucemia acuta mieloide (LAM) con mutazione della nucleofosmina (NPM1) |
| CN114163369A (zh) * | 2021-12-17 | 2022-03-11 | 武汉工程大学 | 一种含硫/氧酯基芳烃化合物的制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011150016A1 (en) * | 2010-05-26 | 2011-12-01 | Abbott Laboratories | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| WO2012071336A1 (en) * | 2010-11-23 | 2012-05-31 | Abbott Laboratories | Salts and crystalline forms of an apoptosis-inducing agent |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB585940A (en) | 1944-09-01 | 1947-02-28 | Kodak Ltd | Bicyclic compounds containing the diphenylamine grouping, process of making them and their use in the colouration of textile materials other than cellulose |
| US3813443A (en) | 1970-11-18 | 1974-05-28 | Us Agriculture | Boll weevil sex attractant |
| ATE482946T1 (de) | 1999-02-10 | 2010-10-15 | Astrazeneca Ab | Chinazolinderivate als angiogenesehemmer und zwischenprodukte dafür |
| ES2391026T3 (es) | 2004-12-02 | 2012-11-20 | Daiichi Sankyo Company, Limited | Compuesto de anillo de 7 miembros, procedimiento para su producción, y uso medicinal del mismo |
| CN1827582A (zh) * | 2006-04-18 | 2006-09-06 | 江苏中丹化工集团公司 | 6－[3－(1－金刚烷基)－4－甲氧基苯基]－2－萘甲酸甲酯的制备方法 |
| NZ580660A (en) * | 2007-04-30 | 2012-02-24 | Abbott Lab | Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| WO2009117626A2 (en) | 2008-03-20 | 2009-09-24 | Abbott Laboratories | Methods for making central nervous system agents that are trpv1 antagonists |
| US20100160322A1 (en) * | 2008-12-04 | 2010-06-24 | Abbott Laboratories | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| UA108193C2 (uk) * | 2008-12-04 | 2015-04-10 | Апоптозіндукуючий засіб для лікування раку і імунних і аутоімунних захворювань | |
| MX2011007681A (es) * | 2009-01-19 | 2011-08-08 | Abbott Lab | Agentes inducidores de apoptosis para el tratamiento del cancer y enfermedades inmunes y autoinmunes. |
| US8546399B2 (en) | 2009-05-26 | 2013-10-01 | Abbvie Inc. | Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases |
| CN101990094B (zh) | 2009-08-05 | 2012-11-21 | 炬力集成电路设计有限公司 | 一种码流分析方法和装置 |
| CN102030651A (zh) * | 2009-09-28 | 2011-04-27 | 莱阳市盛华科技有限公司 | 2-氟-4-溴联苯基甲酸乙酯的合成方法 |
| DE102010027213A1 (de) * | 2010-07-15 | 2012-01-19 | Continental Automotive Gmbh | Verfahren und Steuergerät zum Steuern einer Brennkraftmaschine |
| CN103167867B (zh) | 2010-10-29 | 2016-12-21 | Abbvie 公司 | 含有细胞凋亡诱导药剂的固体分散体 |
| UA113500C2 (xx) | 2010-10-29 | 2017-02-10 | Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб | |
| SI2642999T1 (sl) | 2010-11-23 | 2017-01-31 | Abbvie Ireland Unlimited Company | Postopki zdravljenja z uporabo selektivnih Bcl-2 inhibitorjev |
-
2014
- 2014-03-12 PE PE2019001821A patent/PE20191685A1/es unknown
- 2014-03-12 WO PCT/US2014/024224 patent/WO2014165044A1/en active Application Filing
- 2014-03-12 AU AU2014248742A patent/AU2014248742B2/en active Active
- 2014-03-12 PT PT14715501T patent/PT2970263T/pt unknown
- 2014-03-12 TW TW103108953A patent/TWI631121B/zh active
- 2014-03-12 RS RS20180939A patent/RS57569B1/sr unknown
- 2014-03-12 SG SG10201701680YA patent/SG10201701680YA/en unknown
- 2014-03-12 TW TW107109344A patent/TWI735759B/zh active
- 2014-03-12 EP EP17191299.1A patent/EP3293185A1/en not_active Withdrawn
- 2014-03-12 JP JP2016501441A patent/JP6357220B2/ja active Active
- 2014-03-12 ES ES14715501.4T patent/ES2683378T3/es active Active
- 2014-03-12 KR KR1020157029117A patent/KR102230339B1/ko active IP Right Grant
- 2014-03-12 CN CN201480025215.7A patent/CN105164128B/zh active Active
- 2014-03-12 EP EP14715501.4A patent/EP2970263B1/en active Active
- 2014-03-12 RU RU2015143637A patent/RU2660424C2/ru active
- 2014-03-12 UY UY0001039848A patent/UY39848A/es unknown
- 2014-03-12 HU HUE14715501A patent/HUE039046T2/hu unknown
- 2014-03-12 EP EP21194409.5A patent/EP3954687A1/en active Pending
- 2014-03-12 BR BR112015021540-8A patent/BR112015021540B1/pt active IP Right Grant
- 2014-03-12 BR BR122021025053-7A patent/BR122021025053B1/pt active IP Right Grant
- 2014-03-12 EP EP19183264.1A patent/EP3569588A1/en not_active Withdrawn
- 2014-03-12 EP EP22154798.7A patent/EP4019491A1/en active Pending
- 2014-03-12 CA CA3090936A patent/CA3090936C/en active Active
- 2014-03-12 MX MX2015012000A patent/MX365343B/es active IP Right Grant
- 2014-03-12 PE PE2015001892A patent/PE20151809A1/es unknown
- 2014-03-12 PL PL14715501T patent/PL2970263T3/pl unknown
- 2014-03-12 UY UY0001039847A patent/UY39847A/es not_active Application Discontinuation
- 2014-03-12 MY MYPI2019006129A patent/MY192466A/en unknown
- 2014-03-12 BR BR122021025062-6A patent/BR122021025062B1/pt active IP Right Grant
- 2014-03-12 CN CN201711105971.2A patent/CN107721851B/zh active Active
- 2014-03-12 CN CN202010877947.6A patent/CN111960944A/zh active Pending
- 2014-03-12 SG SG11201507360XA patent/SG11201507360XA/en unknown
- 2014-03-12 LT LTEP14715501.4T patent/LT2970263T/lt unknown
- 2014-03-12 CA CA2903797A patent/CA2903797C/en active Active
- 2014-03-12 CA CA3183040A patent/CA3183040A1/en active Pending
- 2014-03-12 DK DK14715501.4T patent/DK2970263T3/en active
- 2014-03-12 SI SI201430826T patent/SI2970263T1/sl unknown
- 2014-03-12 UY UY0001035394A patent/UY35394A/es active IP Right Grant
- 2014-12-03 UA UAA201509919A patent/UA118667C2/uk unknown
-
2015
- 2015-08-24 IL IL240779A patent/IL240779B/en active IP Right Grant
- 2015-09-04 PH PH12015501960A patent/PH12015501960A1/en unknown
- 2015-09-09 CL CL2015002548A patent/CL2015002548A1/es unknown
- 2015-09-16 CR CR20150495A patent/CR20150495A/es unknown
-
2016
- 2016-04-22 HK HK16104667.6A patent/HK1216644A1/zh unknown
- 2016-04-22 HK HK18110753.6A patent/HK1251231A1/zh unknown
-
2018
- 2018-01-23 IL IL257109A patent/IL257109B/en active IP Right Grant
- 2018-04-13 JP JP2018077547A patent/JP6578037B2/ja active Active
- 2018-05-21 PH PH12018501094A patent/PH12018501094A1/en unknown
- 2018-06-05 AU AU2018203977A patent/AU2018203977B2/en active Active
- 2018-08-09 CY CY20181100834T patent/CY1120576T1/el unknown
- 2018-08-09 HR HRP20181273TT patent/HRP20181273T1/hr unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011150016A1 (en) * | 2010-05-26 | 2011-12-01 | Abbott Laboratories | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| WO2012071336A1 (en) * | 2010-11-23 | 2012-05-31 | Abbott Laboratories | Salts and crystalline forms of an apoptosis-inducing agent |
Non-Patent Citations (3)
| Title |
|---|
| ARREDONDO, J. D. ET AL., ORGANIC SYNTHESES, 2012, vol. 89, page 460-470 * |
| GASSMAN, P. G. ET AL., J. ORG. CHEM, 1977, vol. 42 (5), pages 918 - 920 * |
| RAUSIS, T. ET AL., EUR. J. ORG. CHEM., 2002, pages 3351 - 3358 * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2014248742B2 (en) | Processes for the preparation of an apoptosis-inducing agent | |
| US9199992B2 (en) | Processes for the preparation of an apoptosis-inducing agent | |
| EP3080086B1 (en) | Process of making adamantanamides | |
| CA2896155A1 (en) | Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine | |
| US10253034B2 (en) | Methods for the chemical synthesis of pyrrole-linked bivalent compounds, and compositions thereof | |
| US9238652B2 (en) | Processes for the preparation of an apoptosis-inducing agent | |
| NZ711315B2 (en) | Processes for the preparation of an apoptosis-inducing agent | |
| CN113816955B (zh) | 一种ret激酶抑制剂中间体及其制备方法 | |
| JP4509327B2 (ja) | Ｎ，ｎ−ジ置換−４−アミノクロトン酸エステルの製造方法 | |
| JP2019196359A (ja) | ピリミジン誘導体およびそれらの中間体を調製する化学的方法 | |
| JPS5825662B2 (ja) | グアニジノカプロン酸エステルの製法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| PC | Assignment registered |
Owner name: ABBVIE IRELAND UNLIMITED COMPANY Free format text: FORMER OWNER(S): ABBVIE INC. |